India, Nov. 21 -- Amgen (AMGN) on Thursday raised its adjusted earnings and revenue guidance for the full-year 2019 following the completion of the Otezla acquisition on Wednesday. Otezla, along with certain related assets and liabilities, was acquired for $13.4 billion in cash, or about $11.2 billion, net of the present value of $2.2 billion in anticipated future cash tax benefits.
For fiscal 2019, the company currently projects earnings adjusted earnings in a range of $14.50 to $14.70 per share on total revenues between $23.1 billion and $23.3 billion.
Previously, the company expected adjusted earnings in the range of $14.20 to $14.45 per share on total revenues between $ $22.8 billion and $23.0 billion.
On average, analysts polled by ...